학술논문
Cost-effectiveness of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab in patients with a history of myocardial infarction in Sweden
Document Type
Artikel
Author
Source
European heart journal. Quality of care & clinical outcomes. 8(1):31-38
Subject
Language
English
English
English
ISSN
2058-1742